Eccentric Muscle Training in Cardiac Rehabilitation
Eccentric Muscle Training in Cardiac Rehabilitation: Randomized Controlled Trial to Evaluate Effectiveness and Feasibility in Heart Failure Patients With Reduced Ejection Fraction
University Hospital, Antwerp
3 participants
Jan 20, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this interventional study is to assess the training effects in a training schedule in which eccentric overload training and eccentric cycle training are used. Researchers will compare a training program of eccentric overload training and eccentric cycling training with a traditional training program of strength and cardio training in people with heart failure with reduced ejection fraction. This study will be delivered in a cardiac rehabilitation setting.
Eligibility
Inclusion Criteria3
- HFrEF patients with ejection fraction <40%
- Exercise intolerance (<85% of predicted VO2 peak)
- clinically stable for > 6 weeks, optimal medical treatment for > 6 weeks
Exclusion Criteria5
- Contra indications for cardiac exercise rehabilitation as per consensus guidelines and recommendations
- Musculoskeletal disorders that hamper (progression in) strength training
- Non-stabilized acute coronary syndrome
- Current acute heart failure (decompensation)
- Patient having sustained a recent (<3 months) procedure that could act as a confounder to increase VO2peak (i.e., coronary artery bypass graft surgery, percutaneous coronary intervention, cardiac resynchronization therapy, valve surgery or reparation)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
progressive following protocol, 10min
dynamic strength training + eccentric overload, progressive over time, 3sets\*10reps (15-20min)
aerobic training, progressive over time, 10 min
aerobic training, progressive following protocol, 10 min
dynamic strength training, progression over time, 15-20 min
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07636343